Latest Breaking News On - Equity shares of the company - Page 1 : comparemela.com

Dividend stocks: Vedanta, Tata Consumer Products, QGO Finance shares to trade ex-dividend on May 24

Dividend stocks: Vedanta, Tata Consumer Products, QGO Finance shares to trade ex-dividend on May 24
livemint.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from livemint.com Daily Mail and Mail on Sunday newspapers.

Equity shares of the companyInterim dividendFinancial yearConsumer productsTata consumer productsEquity shareRecord dateBharat dynamicsRecord dateRupees ten onlyEquity sharesRupees five onlySom distilleriesPress gazette

Cello World Limited Proposes Final Dividend for the Financial Year 2023-24, Payable on or After August 15, 2024

Cello World Limited proposed final dividend @ 30% i.e INR 1.50/- each on Equity Shares of the Company of face value of INR 5/- each for the financial year 2023-24, subject to approval of Members at.

Cello worldEquity shares of the companyCello world limitedEquity sharesAnnual general meetingEquity shareholders

BSE : Rights issue of Equity Shares of VSF PROJECTS LIMITED

NOTICES Notice No. 20240521-66 Notice Date .

Trading members of the exchangeEquity shares of the companyEquity sharesRecord dateRights issueEx rights basisRights basisIssue price

Peninsula Land : NOTICE OF EOGM - MarketScreener

Peninsula Land : NOTICE OF EOGM - MarketScreener
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Mukesh guptaGanpatrao kadam margSenapati bapat margPeninsula landStakeholders relationship committeeCompany at rsDelta corpAudit committeeEntity companyArsenio strategies privateMembers of peninsula land limited the companyEquity shares of the companyEquity share of the companyDelta corp limitedNational stock exchange of india limitedExchange board of india

Ajanta Pharma Q4 net profit jumps 66% to Rs 202 72 cr, approves buyback of shares

The Mumbai-based pharma major s revenue came in at Rs 1,054.08 crore, up 20 percent from Rs 881.84 crore a year back.

Ajanta pharmaEquity shares of the companyEquity sharesRupees two thousandSeven hundredSeventy rupeesEquity shareAjanta pharma q4Janta pharma resultsJanta pharma earnings